Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
7.03
+0.10 (1.44%)
At close: Mar 18, 2026, 4:00 PM EDT
7.04
+0.01 (0.14%)
After-hours: Mar 18, 2026, 7:18 PM EDT
Precision BioSciences Market Cap
Precision BioSciences has a market cap or net worth of $173.83 million as of March 18, 2026. Its market cap has increased by 332.74% in one year.
Market Cap
173.83M
Enterprise Value
87.05M
1-Year Change
332.74%
Ranking
Category
Stock Price
$7.03
Market Cap Chart
Since March 28, 2019, Precision BioSciences's market cap has decreased from $855.07M to $173.83M, a decrease of -79.67%. That is a compound annual growth rate of -20.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 173.83M | 73.59% |
| Dec 31, 2025 | 100.14M | 242.63% |
| Dec 31, 2024 | 29.23M | -34.32% |
| Dec 29, 2023 | 44.50M | -66.30% |
| Dec 30, 2022 | 132.04M | -70.64% |
| Dec 31, 2021 | 449.68M | 2.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcturus Therapeutics Holdings | 181.62M |
| Milestone Pharmaceuticals | 180.82M |
| AN2 Therapeutics | 179.71M |
| NovaBay Pharmaceuticals | 177.65M |
| Korro Bio | 177.54M |
| ProMIS Neurosciences | 175.32M |
| Eledon Pharmaceuticals | 172.60M |
| Corbus Pharmaceuticals Holdings | 170.80M |